From ToxBankWiki

Jump to: navigation, search

SA461 (BF461)

Cell Nomenclature SA461 (BF461)
hESCreg Database SA461 (BF461) entry
UKSCB Acc. No. SA461
Provenance Male
1. Kane, N.M., Howard, L., Descamps, B., Meloni, M., McClure, J., Lu, R., McCahill, A., Breen, C., Mackenzie, R.M., Delles, C., Mountford, J.C., Milligan, G., Emanueli, C. and Baker, A.H., 2012, Role of microRNAs 99b, 181a, and 181b in the differentiation of human embryonic stem cells to vascular endothelial cells. Stem Cells. 30(4):643-54.
2. Darnfors, C., Flodin, A., Andersson, K., Caisander, G., Lindqvist, J., Hyllner, J., Wahlström, J. and Sartipy, P., 2005, High-Resolution Analysis of the Subtelomeric Regions of Human Embryonic Stem Cells. Stem Cells. 23:483–488.
3. Howard, L., Mackenzie, R.M., Pchelintsev, N.A., McBryan, T., McClure, J.D., McBride, M.W., Kane, N.M., Adams, P.D., Milligan, G. and Baker, A.H., 2013, Profiling of transcriptional and epigenetic changes during directed endothelial differentiation of human embryonic stem cells identifies FOXA2 as a marker of early mesoderm commitment. Stem Cell Research & Therapy. 4:36.
4. Kane, N.M., Meloni, M., Spencer, H.L., Craig, M.A., Strehl, R., Milligan, G., Houslay, M.D., Mountford, J.C., Emanueli, C., Baker, A.H., 2010, Derivation of Endothelial Cells From Human Embryonic Stem Cells by Directed Differentiation Analysis of MicroRNA and Angiogenesis In Vitro and In Vivo. Arterioscler Thromb Vasc Biol. 30:1389-1397.
5. Burton, P., Adams, D.R., Abraham, A., Allcock, R.W., Jiang, Z., McCahill, A., Gilmour, J., McAbney, J., Kane, N.M., Baillie, G.S., McKenzie, F.R., Baker, A.H., Houslay, M.D., Mountford, J.C. and Milligan, G., 2010, Identification and characterization of small-molecule ligands that maintain pluripotency of human embryonic stem cells. Biochemical Society Transactions, 38 (4):1058-1061.
6. Catalina, P., Montes, R., Ligero, G., Sanchez, L., de la Cueva, T., Bueno, C., Leone, P.E. and Menendez, P., 2008, Human ESCs predisposition to karyotypic instability: Is a matter of culture adaptation or differential vulnerability among hESC lines due to inherent properties? Molecular Cancer, 7:76.
SEURAT Protocols Search for Protocols in the ToxBank Data Warehouse
SEURAT Data Search for Data in the ToxBank Data Warehouse
Other Links
Requesting Procedure Contact Cellectis

Authors of this ToxBank wiki page

Glenn Myatt
Personal tools
Renal Toxins
Special Substances
Undifferentiated Stem Cells
hiPSC Lines
Liver Cell Lines
iPS-derived Cardiomyocytes
Reagents (Growth Factors)
Reagents (Antibodies)
Reagents (Others)
Suppliers (Cells)